EMA – Open consultation on the Draft guideline on the pharmaceutical quality of inhalation and nasal medicinal products
This guideline replaces the guideline on pharmaceutical quality of inhalation and nasal products (EMEA/CHMP/QWP/49313/2005 Corr) and Quality of medicines questions and answers: Part 2 Specific type of products – Dry product inhalers; Orally inhaled products; Storage – What are the requirements for storage orientation recommendations in the product information for pressurised metered dose inhalers.
Comments should be provided using this EUSurvey form. For any technical issues, please contact the EUSurvey Support.
The consultation closes on 31 October.
More information on ongoing consultations on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (4 octobre 2024). EMA – Open consultation on the Draft guideline on the pharmaceutical quality of inhalation and nasal medicinal products. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/12f6n





